Both in Biotechnology
Ginkgo Bioworks Holdings vs Candel Therapeutics
Over the past year DNA returned +0.5% and CADL returned +76.4%; their daily moves had a correlation of 0.35.
DNA +0.5% CADL +76.4%Growth of $1, one year, split-adjusted
| Metric | DNA | CADL |
|---|---|---|
| Price | $11.65 | $9.05 |
| Market cap | $784.5M | $692.5M |
| Today | +8.27% | +2.61% |
| 1 month | −6.1% | −8.3% |
| 6 months | +15.6% | +18.6% |
| Year to date | +40.2% | +60.2% |
| 1 year | −8.9% | +73.4% |
| Revenue growth (YoY) | −48.5% | — |
| Gross margin | 91.5% | — |
| Net margin | −231.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.0× | — |
| Net cash | $302.2M | $153.7M |
| Dividend yield | — | — |
| Volatility (60d) | 128.9% | 67.7% |
| Short % of float | 18.4% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).